严重肢体缺血血管内或外科治疗后30天再入院分析
再入院独立预测因素包括溃疡或坏疽表现、年龄≥65岁、女性、医院规模大、教学医院、合并症及院内并发症,血运重建方式与再入院无关。再入院最常见原因为感染(23.5%)、外周动脉疾病持续或复发表现(22.2%)、心脏情况(11.4%)。
要点
- CLI住院血运重建后约1/5患者30天内再入院。
- 再入院风险与CLI表现、人口学、合并症及院内并发症相关,与血运重建方式无关。
- 感染和外周动脉疾病复发是再入院最常见原因。
核心结论
- 约1/5因CLI住院并接受血运重建的患者在30天内再入院,风险受CLI表现、人口学、合并症及院内并发症影响,与血运重建方式无关。
主要发现
- 30天再入院率为20.4%。
- 再入院的独立预测因素包括溃疡或坏疽表现、年龄≥65岁、女性、医院规模大、教学医院、已知冠心病、心力衰竭、糖尿病、慢性肾脏病、贫血、凝血障碍、肥胖、大出血、急性心肌梗死、血管并发症和脓毒症;血运重建方式与再入院无独立关联。
- 再入院最常见原因为感染(23.5%)、外周动脉疾病持续或复发表现(22.2%)、心脏情况(11.4%)、操作并发症(11.0%)和内分泌问题(5.7%)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thirty-day readmission rates have gained increasing importance as a key quality metric. A significant number of patients are hospitalized for the management of critical limb ischemia (CLI), but limited data are available on the incidence, predictors, and causes of 30-day readmission after hospitalization for CLI. METHODS: Hospitalizations for a primary diagnosis of CLI during which patients underwent endovascular or surgical therapy (revascularization and/or amputation) and were discharged alive were identified in the 2013 to 2014 Nationwide Readmissions Databases. Incidence, reasons, and costs of 30-day unplanned readmissions were determined. Hierarchical logistic regression models were used to identify independent predictors of 30-day readmissions. RESULTS: We included 60 998 (national estimate, 135 110) index CLI hospitalizations (mean age, 68.9±11.9 years; 40.8% women; 24.6% for rest pain, 37.2% for ulcer, and 38.2% for gangrene). The 30-day readmission rate was 20.4%. Presentation with ulcer or gangrene, age ≥65 years, female sex, large hospital size, teaching hospital status, known coronary artery disease, heart failure, diabetes mellitus, chronic kidney disease, anemia, coagulopathy, obesity, major bleeding, acute myocardial infarction, vascular complications, and sepsis were identified as independent predictors of 30-day readmission. Mode of revascularization was not independently associated with readmissions. Infections (23.5%), persistent or recurrent manifestations of peripheral artery disease (22.2%), cardiac conditions (11.4%), procedural complications (11.0%), and endocrine issues (5.7%) were the most common reasons for readmission. The inflation-adjusted aggregate costs of 30-day readmissions for CLI during the study period were $624 million. CONCLUSIONS: Approximately 1 in 5 patients hospitalized for CLI and undergoing revascularization is readmitted within 30 days. Risk of readmission is influenced by CLI presentation, patient demographics, comorbidities, and in-hospital complications, but not by the mode of revascularization.
引用
- Kolte D, Kennedy KF, Shishehbor MH, et al. Thirty-Day Readmissions After Endovascular or Surgical Therapy for Critical Limb Ischemia: Analysis of the 2013 to 2014 Nationwide Readmissions Databases. Circulation. 2017. PMID: 28465288. doi:10.1161/CIRCULATIONAHA.117.027625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。